Berubicin hydrochloride, Cecenu® 40 mg Kapsel clinical trials

A Multicenter, Open-Label Study with a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients with Recurrent Glioblastoma Multiforme (WHO Grade IV) After Failure of Standard First Line Therapy

This study is testing a new medicine called berubicin for adults with a serious type of brain tumour called glioblastoma, which has come back after standard treatments. We want to see if it helps people live longer and if it's safe.